Added to YB: 2025-12-11
Pitch date: 2025-12-09
SMTI [bullish]
Sanara MedTech Inc.
+9.32%
current return
Author Info
Company Info
Sanara MedTech Inc., a medical technology company, develops, markets, and distributes surgical, wound, and skincare products and services to physicians, hospitals, clinics, and post-acute care settings in the United States.
Market Cap
$194.4M
Pitch Price
$23.70
Price Target
43.50 (+68%)
Dividend
N/A
EV/EBITDA
40.50
P/E
-30.77
EV/Sales
2.23
Sector
Health Care Equipment and Supplies
Category
value
Sanara MedTech (SMTI): Broken Growth Story or Buying Opportunity?
SMTI: Trading <2x EV/Sales (lowest since IPO) despite 80%+ gross margins, category-leading hydrolyzed collagen CellerateRX with 5% market penetration vs 2M addressable surgeries. Discontinued THP moonshot, now profitable surgical focus. BIASURGE launched 2023, OsStic Q1 2027. 15%+ growth est, peers trade 4-9x sales.
Read full article (12 min)